Angélica Torres-Berrío

Angélica Torres-Berrío

Auto-generated profile, based on publicly available information

Angélica Torres-Berrío

Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Biological Psychiatry
Verified
Journal Article
Open access
ATAngélica Torres-Berrío
Angélica Torres-Berrío
JLJuan Pablo Lopez
Juan Pablo Lopez
RBRosemary C. Bagot
Rosemary C. Bagot
DNDominique Nouel
Dominique Nouel
GBGregory Dal Bo
Gregory Dal Bo
CFCecilia Flores
Cecilia Flores
Variations in the expression of the Netrin-1 guidance cue receptor DCC (deleted in colorectal cancer) appear to confer resilience or susceptibility to psychopathologies involving prefrontal cortex (PFC) dysfunction. With the use of postmortem brain tissue, mouse models of defeat stress, and in vitro analysis, we assessed microRNA (miRNA) regulation of DCC and whether changes in DCC levels in the PFC lead to vulnerability to depression-like behaviors. We identified miR-218 as a posttranscriptional repressor of DCC and detected coexpression of DCC and miR-218 in pyramidal neurons of human and mouse PFC. We found that exaggerated expression of DCC and reduced levels of miR-218 in the PFC are consistent traits of mice susceptible to chronic stress and of major depressive disorder in humans. Remarkably, upregulation of Dcc in mouse PFC pyramidal neurons causes vulnerability to stress-induced social avoidance and anhedonia. These data are the first demonstration of microRNA regulation of DCC and suggest that, by regulating DCC, miR-218 may be a switch of susceptibility versus resilience to stress-related disorders.

17 April 2020 in Neuron
Verified
Journal Article
Closed access
OIOrna Issler
Orna Issler
YZYentl Y. van der Zee
Yentl Y. van der Zee
ARAarthi Ramakrishnan
Aarthi Ramakrishnan
JWJunshi Wang
Junshi Wang
CTChunfeng Tan
Chunfeng Tan
ENEric J Nestler
Eric J Nestler

16 December 2020 in Nature
Verified
Journal Article
Closed access
PDF file
AAArgel Aguilar-Valles
Argel Aguilar-Valles
DGDanilo De Gregorio
Danilo De Gregorio
EMEdna Matta-Camacho
Edna Matta-Camacho
MEMohammad J. Eslamizade
Mohammad J. Eslamizade
AKAbdessattar Khlaifia
Abdessattar Khlaifia
NSNahum Sonenberg
Nahum Sonenberg

1 January 2018 in Biological Psychiatry
Verified
Journal Article
Closed access
LRLauren M. Reynolds
Lauren M. Reynolds
MPMatthew Pokinko
Matthew Pokinko
ATAngélica Torres-Berrío
Angélica Torres-Berrío
SCSantiago Cuesta
Santiago Cuesta
LLLaura C. Lambert
Laura C. Lambert
CFCecilia Flores
Cecilia Flores

17 December 2013 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
CMC Manitt
C Manitt
CEC Eng
C Eng
MPM Pokinko
M Pokinko
RRR T Ryan
R T Ryan
ATA Torres-Berrío
A Torres-Berrío
CFC Flores
C Flores
Adolescence is a period of heightened susceptibility to psychiatric disorders of medial prefrontal cortex (mPFC) dysfunction and cognitive impairment. mPFC dopamine (DA) projections reach maturity only in early adulthood, when their control over cognition becomes fully functional. The mechanisms governing this protracted and unique development are unknown. Here we identify dcc as the first DA neuron gene to regulate mPFC connectivity during adolescence and dissect the mechanisms involved. Reduction or loss of dcc from DA neurons by Cre-lox recombination increased mPFC DA innervation. Underlying this was the presence of ectopic DA fibers that normally innervate non-cortical targets. Altered DA input changed the anatomy and electrophysiology of mPFC circuits, leading to enhanced cognitive flexibility. All phenotypes only emerged in adulthood. Using viral Cre, we demonstrated that dcc organizes mPFC wiring specifically during adolescence. Variations in DCC may determine differential predisposition to mPFC disorders in humans. Indeed, DCC expression is elevated in brains of antidepressant-free subjects who committed suicide.

31 December 2019 in Dialogues in clinical neuroscience
Verified
Journal Article
Open access
ATAngélica Torres-Berrío
Angélica Torres-Berrío
OIOrna Issler
Orna Issler
EPEric M. Parise
Eric M. Parise
ENEric J Nestler
Eric J Nestler
Depression is a devastating psychiatric disorder caused by a combination of genetic predisposition and life events, mainly exposure to stress. Early life stress (ELS) in particular is known to "scar" the brain, leading to an increased susceptibility to developing depression later in life via epigenetic mechanisms. Epigenetic processes lead to changes in gene expression that are not due to changes in DNA sequence, but achieved via modulation of chromatin modifications, DNA methylation, and noncoding RNAs. Here we review common epigenetic mechanisms including the enzymes that take part in reading, writing, and erasing specific epigenetic marks. We then describe recent developments in understanding how ELS leads to changes in the epigenome that are manifested in increased susceptibility to depression-like abnormalities in animal models. We conclude with highlighting the need for future studies that will potentially enable the utilisation of the understanding of epigenetic changes linked to ELS for the development of much-needed novel therapeutic strategies and biomarker discovery. .